Imaging techniques valuable in glaucoma diagnosis

Article

Data from the ongoing European Optic Disc Assessment Trial (EODAT) indicated that imaging techniques could be valuable assets to ophthalmologists in the diagnosis of glaucoma, according to Nic Reus, MD, from the Glaucoma Service of The Rotterdam Eye Hospital, Rotterdam, The Netherlands.

Data from the ongoing European Optic Disc Assessment Trial (EODAT) indicated that imaging techniques could be valuable assets to ophthalmologists in the diagnosis of glaucoma, according to Nic Reus, MD, from the Glaucoma Service of The Rotterdam Eye Hospital, Rotterdam, The Netherlands.

"Glaucoma can be difficult to diagnose," Dr. Reus said. "The IOP may not be elevated in up to 50% of patients, and up to 50% of retinal ganglion cells may be lost early in the disease process."

The EODAT was designed to determine the accuracy and repeatability of European ophthalmologists in classifying stereoscopic optic disc photographs as healthy or glaucomatous and to compare their accuracy with that of GDxVCC (Carl Zeiss Meditec) and the Heidelberg Retina Tomograph (Heidelberg Engineering).

Stereoscopic optic disc photographs from 48 patients with glaucoma and 40 healthy individuals were evaluated. Sixteen photographs of healthy and glaucomatous eyes were duplicated for assessing intraobserver agreement, expressed as kappa. A total of 207 ophthalmologists classified the disc photographs as normal or glaucomatous.

Dr. Reus reported that the overall accuracy of the ophthalmologists in correctly classifying the photographs was 80.8%. In comparison, the GDxVCC, Heidelberg Retina Tomography, and Heidelberg Retina Tomography with Moorfields regression analysis correctly classified the photographs 93.2%, 89.8%, and 86.4%, respectively.

"Classification appears better by imaging than by most ophthalmologists. Classification is difficult for ophthalmologists," Dr. Reus concluded. "There were large variations among ophthalmologists and among countries. Imaging techniques appear to be better on average than ophthalmologists and these imaging techniques can be helpful to ophthalmologists in the diagnosis of glaucoma."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.